Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dhanak

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
The Journal of Biological Chemistry|August 9, 2002
Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymeraseDashyant Dhanak, Kevin J Duffy, Victor K Johnston, et al.
Blood|September 10, 2024
Selective targeting of mutated calreticulin by the monoclonal antibody INCA033989 inhibits oncogenic function of MPNEdimara S Reis, Rebecca Buonpane, Hamza Celik, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2Sharad K Verma, Xinrong Tian, Louis V LaFrance, et al.
Cell|January 27, 2018
Targeting KRAS Mutant Cancers with a Covalent G12C-Specific InhibitorMatthew R Janes, Jingchuan Zhang, Lian-Sheng Li, et al.
Science (New York, N.Y.)|March 9, 2019
A small-molecule fusion inhibitor of influenza virus is orally active in miceMaria J P van Dongen, Rameshwar U Kadam, Jarek Juraszek, et al.
Journal of Medicinal Chemistry|August 30, 2007
Novel ATP-competitive kinesin spindle protein inhibitorsCynthia A Parrish, Nicholas D Adams, Kurt R Auger, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2010
Antitumor activity of an allosteric inhibitor of centromere-associated protein-EKenneth W Wood, Latesh Lad, Lusong Luo, et al.
Journal of Medicinal Chemistry|April 28, 2010
Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinaseNicholas D Adams, Jerry L Adams, Joelle L Burgess, et al.
Cancer Cell|July 16, 2015
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLCHelai P Mohammad, Kimberly N Smitheman, Chandrashekhar D Kamat, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of RapamycinSteven D Knight, Nicholas D Adams, Joelle L Burgess, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
The Journal of Biological Chemistry|August 9, 2002
Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymeraseDashyant Dhanak, Kevin J Duffy, Victor K Johnston, et al.
Blood|September 10, 2024
Selective targeting of mutated calreticulin by the monoclonal antibody INCA033989 inhibits oncogenic function of MPNEdimara S Reis, Rebecca Buonpane, Hamza Celik, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2Sharad K Verma, Xinrong Tian, Louis V LaFrance, et al.
Cell|January 27, 2018
Targeting KRAS Mutant Cancers with a Covalent G12C-Specific InhibitorMatthew R Janes, Jingchuan Zhang, Lian-Sheng Li, et al.
Science (New York, N.Y.)|March 9, 2019
A small-molecule fusion inhibitor of influenza virus is orally active in miceMaria J P van Dongen, Rameshwar U Kadam, Jarek Juraszek, et al.
Journal of Medicinal Chemistry|August 30, 2007
Novel ATP-competitive kinesin spindle protein inhibitorsCynthia A Parrish, Nicholas D Adams, Kurt R Auger, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2010
Antitumor activity of an allosteric inhibitor of centromere-associated protein-EKenneth W Wood, Latesh Lad, Lusong Luo, et al.
Journal of Medicinal Chemistry|April 28, 2010
Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinaseNicholas D Adams, Jerry L Adams, Joelle L Burgess, et al.
Cancer Cell|July 16, 2015
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLCHelai P Mohammad, Kimberly N Smitheman, Chandrashekhar D Kamat, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of RapamycinSteven D Knight, Nicholas D Adams, Joelle L Burgess, et al.
Pageof 15